Transpara review
Breast-imaging AI combining detection, risk stratification, density and prior comparison.
Reviewed by iTechGuides Editors · Editorial team · Updated Nov 2026
Transpara is ScreenPoint Medical’s breast-imaging AI suite for radiologists and breast-screening providers. It analyzes 2D/FFDM and 3D/DBT mammograms, supports concurrent reading, and adds risk information to the examination. The suite is aimed at mid-market and enterprise organizations that need detection assistance, examination prioritization and structured breast-density assessment within existing imaging workflows. ScreenPoint states that Transpara is FDA cleared and CE marked for 2D and 3D mammography and is used in more than 30 countries.
Its strongest contribution is the combination of detection and workflow support. Transpara Detection marks regions of risk and assigns Elevated, Intermediate or Low exam categories, supporting triage of higher-risk examinations. Transpara Density provides automated assessment with a BI-RADS-like result and volumetric density, while Temporal Comparison lets radiologists review changes across up to three prior mammograms. These capabilities give screening teams several analysis layers without limiting the product to a single detection output.
Purchasing follows a contact-sales model rather than published subscription plans, so organizations should plan for a demo-led evaluation. Transpara is designed to integrate with existing imaging systems and platforms, although the available integration details are presented at a general level. Product availability and features may vary by country. Breast-screening programs seeking mammography detection, prioritization, density assessment and prior comparison should consider Transpara; teams needing cardiac or pathology analytics should look to a different product category.
Transpara pros and cons
- Where it wins
- Analyzes both 2D/FFDM and 3D/DBT mammograms for cancer detection
- Adds Elevated, Intermediate and Low exam-risk categories with region markings
- Automates density assessment and compares up to three prior mammograms
- Where it doesn't
- Pricing is handled through a demo and contact-sales process
- Integration information is described broadly rather than by named platforms
- Its scope centers on breast imaging, not cardiac or pathology analytics
Transpara fact sheet, pricing and score →
Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.
Last updated · How we research and update